Most Recent
CIMIC faces bid for indemnity costs after last-minute subpoenas derailed class action trial
The lead applicant in a shareholder class action against global engineering firm CIMIC Group has made a bid for indemnity costs, after a last-minute subpoena of three former executives led to the trial being vacated.
Judge finds real risk of ASIC case against former IOOF exec
Former IOOF chairman George Venardos will be allowed to object to incriminating evidence and discovery in proceedings brought by APRA, after a court found there was a real and appreciable risk that ASIC could also bring a civil case against him.
APRA ordered to hand over ASIC chats about IOOF exec
APRA has been ordered to hand over all of its correspondence with fellow regulator ASIC relating to former IOOF chairman George Venardos, as he prepares to argue privilege over discovery that might incriminate him in any possible ASIC proceedings.
Ultra Tune’s excuse for missing appeal deadline doesn’t wash, ACCC tells court
The consumer regulator wants a court to throw out Ultra Tune’s appeal of a $2.6 million penalty after the national car repair franchise filed its challenge more than a month late because its lawyers "miscalculated" the deadline.
Fair Work Ombudsman wins appeal over CFMEU penalty in Hutchison Ports strike case
An appeals court has handed a win to the Fair Work Ombudsman in its battle for a multimillion dollar penalty against the CFMEU for coordinated strikes at two Hutchison Ports shipping terminals, finding a judge's fine of just $38,000 did not cut it.
IOOF chair told APRA conflicts of interest were ‘a bit of a non-event’
The former chairman of troubled IOOF told APRA during a review meeting that he "struggled" to think the wealth manager had any conflicts of interest and that the issue was getting too much "airplay", according to court documents filed recently by the prudential regulator.
Sandoz entitled to generic Lexapro licence, IP Australia finds in blow to Lundbeck
Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.
Lundbeck sues IP Australia, Sandoz to escape undertaking over Lexapro licence
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court's decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
Judge ‘uncomfortable’ with common fund order in toxic foam class actions
A judge overseeing three toxic foam class actions against the Commonwealth of Australia has said he's not comfortable approving a common fund order which does not detail specific remuneration amounts for funder IMF Bentham.
Deep Investments can’t take another shot at case, Full Court says
The Full Court has denied a bid by Deep Investments to vary orders dismissing its case against a solicitor and six others over $10 million in alleged share trading losses, saying this would amount to allowing the investment adviser to bring a different claim.